{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:10:24Z","timestamp":1759594224974,"version":"build-2065373602"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,4]]},"DOI":"10.7759\/cureus.93835","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:30:50Z","timestamp":1759591850000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Impact of Age and Sex on Survival in Localised Anterior Uveal Melanoma Undergoing Eye-Preserving Interventions Within a Surveillance, Epidemiology, and End Results (SEER) Cohort"],"prefix":"10.7759","author":[{"given":"Michael","family":"Milad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Almanasra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Al-khazaleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarankan","family":"Sriranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki S","year":"2017","unstructured":"Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye (Lond). 2017, 31:241-57. 10.1038\/eye.2016.275","journal-title":"Eye (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2020.00318","article-title":"Clinical management of uveal melanoma: a comprehensive review with a treatment algorithm","volume":"38","author":"Sayan M","year":"2020","unstructured":"Sayan M, Mamidanna S, Oncel D, et al.. Clinical management of uveal melanoma: a comprehensive review with a treatment algorithm. Radiat Oncol J. 2020, 38:162-9. 10.3857\/roj.2020.00318","journal-title":"Radiat Oncol J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2016.07.06","article-title":"Proton therapy for the management of uveal melanoma and other ocular tumors","volume":"5","author":"Mishra KK","year":"2016","unstructured":"Mishra KK, Daftari IK. Proton therapy for the management of uveal melanoma and other ocular tumors. Chin Clin Oncol. 2016, 5:50. 10.21037\/cco.2016.07.06","journal-title":"Chin Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala E","year":"2003","unstructured":"Kujala E, M\u00e4kitie T, Kivel\u00e4 T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003, 44:4651-9. 10.1167\/iovs.03-0538","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5458","article-title":"Sex-based differences in early and late uveal melanoma-related mortality","volume":"12","author":"St\u00e5lhammar G","year":"2023","unstructured":"St\u00e5lhammar G. Sex-based differences in early and late uveal melanoma-related mortality. Cancer Med. 2023, 12:6700-10. 10.1002\/cam4.5458","journal-title":"Cancer Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields CL","year":"2012","unstructured":"Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012, 32:1363-72. 10.1097\/IAE.0b013e31824d09a8","journal-title":"Retina"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000543151","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1975-2020)","volume":"11","author":"Weinberger Y","year":"2025","unstructured":"Weinberger Y, Bena J, Singh AD. Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1975-2020). Ocul Oncol Pathol. 2025, 11:30-6. 10.1159\/000543151","journal-title":"Ocul Oncol Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.926034","article-title":"Trends in uveal melanoma presentation and survival during five decades: a nationwide survey of 3898 Swedish patients","volume":"9","author":"Gill V","year":"2022","unstructured":"Gill V, Herrspiegel C, Sabazade S, et al.. Trends in uveal melanoma presentation and survival during five decades: a nationwide survey of 3898 Swedish patients. Front Med (Lausanne). 2022, 9:926034. 10.3389\/fmed.2022.926034","journal-title":"Front Med (Lausanne)"},{"key":"ref9","unstructured":"Surveillance, Epidemiology, and End Results (SEER) program. SEER*Stat database. incidence - SEER 17 registries (2000-2019). (2022). Accessed: 10\/9\/2025: https:\/\/seer.cancer.gov\/."},{"key":"ref10","unstructured":"SEER*Stat software, version 8.4.2. (2022). Accessed. 10\/09\/2025: https:\/\/seer.cancer.gov\/seerstat\/."},{"key":"ref11","article-title":"International Classification of Diseases for Oncology (ICD-O), 3d ed. Volume 79","author":"World Health Organization","year":"2001","unstructured":"World Health Organization. International Classification of Diseases for Oncology (ICD-O), 3d ed. Volume 79. World Health Organization, Geneva; 2001."},{"key":"ref12","article-title":"","author":"Young JL Jr RS","year":"2001","unstructured":"Young JL Jr RS, Ries LAG, Fritz AG, Hurlbut AA. SEER Summary Staging Manual - 2000: Codes and Coding Instructions. National Cancer Institute, Bethesda; 2001. https:\/\/seer.cancer.gov\/tools\/ssm\/ssm2000\/."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan EL","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53:457-81. 10.1080\/01621459.1958.10501452","journal-title":"J Am Stat Assoc"},{"key":"ref14","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel N","year":"1966","unstructured":"Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966, 50:163-70.","journal-title":"Cancer Chemother Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox DR","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Ser B Stat Methodol. 1972, 34:187-220. 10.1111\/j.2517-6161.1972.tb00899.x","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"ref16","unstructured":"R. The R Project for Statistical Computing. (2024). Accessed: 10\/09\/2025: https:\/\/www.R-project.org\/."},{"key":"ref17","unstructured":"survival. A package for survival analysis in R (version 3.5-7). (2024). Accessed: 10\/09\/2025: https:\/\/cran.r-project.org\/web\/packages\/survival\/index.html."},{"key":"ref18","unstructured":"survminer. Drawing survival curves using ggplot2 (version 0.4.9). (2024). Accessed: 10\/09\/2025: https:\/\/cran.r-project.org\/web\/\/packages\/\/survminer\/survminer.pdf."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian J","year":"2020","unstructured":"Lian J, Yue Y, Yu W, Zhang Y. Immunosenescence: a key player in cancer development. J Hematol Oncol. 2020, 13:151. 10.1186\/s13045-020-00986-z","journal-title":"J Hematol Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.04.008","article-title":"Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach","volume":"55","author":"Janssen-Heijnen ML","year":"2005","unstructured":"Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol. 2005, 55:231-40. 10.1016\/j.critrevonc.2005.04.008","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour JW","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson ED, et al.. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010, 330:1410-3. 10.1126\/science.1194472","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2012.255","article-title":"Molecular pathology of uveal melanoma","volume":"27","author":"Coupland SE","year":"2013","unstructured":"Coupland SE, Lake SL, Zeschnigk M, Damato BE. Molecular pathology of uveal melanoma. Eye (Lond). 2013, 27:230-42. 10.1038\/eye.2012.255","journal-title":"Eye (Lond)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10365","article-title":"Gender differences in clinical presentation and prognosis of uveal melanoma","volume":"54","author":"Zloto O","year":"2013","unstructured":"Zloto O, Pe'er J, Frenkel S. Gender differences in clinical presentation and prognosis of uveal melanoma. Invest Ophthalmol Vis Sci. 2013, 54:652-6. 10.1167\/iovs.12-10365","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S113623","article-title":"Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012)","volume":"10","author":"Mahendraraj K","year":"2016","unstructured":"Mahendraraj K, Lau CS, Lee I, Chamberlain RS. Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012). Clin Ophthalmol. 2016, 10:2113-9. 10.2147\/OPTH.S113623","journal-title":"Clin Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05317-7","article-title":"The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015","volume":"260","author":"Alfaar AS","year":"2022","unstructured":"Alfaar AS, Saad A, Wiedemann P, Rehak M. The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. Graefes Arch Clin Exp Ophthalmol. 2022, 260:1723-31. 10.1007\/s00417-021-05317-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09002-0","article-title":"No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter","volume":"21","author":"Sabazade S","year":"2021","unstructured":"Sabazade S, Herrspiegel C, Gill V, St\u00e5lhammar G. No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter. BMC Cancer. 2021, 21:1270. 10.1186\/s12885-021-09002-0","journal-title":"BMC Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh AD","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011, 118:1881-5. 10.1016\/j.ophtha.2011.01.040","journal-title":"Ophthalmology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5114\/jcb.2022.115210","article-title":"Contemporary trends in management of uveal melanoma","volume":"14","author":"Chevli N","year":"2022","unstructured":"Chevli N, Zuhour RJ, Messer JA, et al.. Contemporary trends in management of uveal melanoma. J Contemp Brachytherapy. 2022, 14:123-9. 10.5114\/jcb.2022.115210","journal-title":"J Contemp Brachytherapy"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13633","article-title":"Iodine plaque brachytherapy a customized conservative approach to the management of medium\/large-sized uveal melanoma","volume":"38","author":"Laliscia C","year":"2024","unstructured":"Laliscia C, Perrone F, Cresti F, et al.. Iodine plaque brachytherapy a customized conservative approach to the management of medium\/large-sized uveal melanoma. In Vivo. 2024, 38:1814-22. 10.21873\/invivo.13633","journal-title":"In Vivo"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.02.022","article-title":"Second primary neoplasms in patients with uveal melanoma: a SEER database analysis","volume":"165","author":"La\u00edns I","year":"2016","unstructured":"La\u00edns I, Bartosch C, Mondim V, Healy B, Kim IK, Husain D, Miller JW. Second primary neoplasms in patients with uveal melanoma: a SEER database analysis. Am J Ophthalmol. 2016, 165:54-64. 10.1016\/j.ajo.2016.02.022","journal-title":"Am J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/416765-evaluating-the-impact-of-age-and-sex-on-survival-in-localised-anterior-uveal-melanoma-undergoing-eye-preserving-interventions-within-a-surveillance-epidemiology-and-end-results-seer-cohort","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:30:52Z","timestamp":1759591852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/416765-evaluating-the-impact-of-age-and-sex-on-survival-in-localised-anterior-uveal-melanoma-undergoing-eye-preserving-interventions-within-a-surveillance-epidemiology-and-end-results-seer-cohort"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.93835","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,4]]}}}